RWJBarnabas Health Achieve ACC Cardiac Cath Lab Service

As the health system with the largest network of Cardiac Cath labs in New Jersey, our commitment to Quality is demonstrated in what we do every day. The market is experiencing significant growth, which is driven by the increasing prevalence of cardiovascular diseases and the demand for advanced diagnostic and therapeutic capabilities, and is influenced by technological advancements, such as the adoption of new cardiac lab technologies and the integration of artificial intelligence in diagnostics.

This program is designed to advance quality, strengthen operational performance, and support better patient outcomes.
MD, MBA, Chief Clinical Officer, RWJBarnabas Health Heart & Vascular Conor Barrett, explained that "Achieving system wide ACC accreditation underscores our commitment, which helps to deliver high quality cardiac care to every community that we serve across the entire state of New Jersey. With this coordination and effort, RWJBarnabas Health sets itself apart as New Jersey’s premier destination for heart care.

According to Towards Healthcare, the U.S. cath labs market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 7.31 billion in 2026 to approximately USD 13.33 billion by 2035, representing a compound annual growth rate (CAGR) of 6.9% from 2026 to 2035. Growth is driven by the rising burden of chronic illness and continuous increase in cardiovascular diseases, which often exacerbated by poor diets, sedentary lifestyles, and stress that creates a high volume of necessary angioplasties, stenting, and diagnostic procedures with technological integration and innovation of artificial intelligence (AI), advanced catheter technologies, and superior imaging systems like 3D mapping and robotics allows for safer, more precise procedures

About RWJBarnabas Health

RWJBarnabas Health (RWJBH) is a provider in the U.S. cardiac catheterization lab market, operating in New Jersey with the most extensive academic cardiovascular network. Its cath labs are widely recognized for elite quality, advanced robotics, and pioneering cross-disciplinary research in the rapidly growing multibillion-dollar catheterization market.
It operates across 12 hospitals, including four high-volume cardiac surgery centres, positioning itself as a dominant provider in the highly competitive NY/NJ Metro market. With advanced capabilities and tech innovation, it becomes easy to collaborate with Rutgers and SciTech. RWJBH is pioneering the use of artificial intelligence and advanced digital health to improve patient outcomes.

A recent report by Towards Healthcare highlights that the U.S. cath labs market is witnessing growth due to a strong growing opportunity within Outpatient Cardiac Catheterization Facilities, driven by favorable reimbursement policies and shifting patient preference, and innovation in catheter technologies continues to expand the types of procedures feasible outside of open-heart surgery.